Terumo Corporation (TRUMY)
USD 19.28
(-2.92%)
USD 19.28
(-2.92%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 220.34 Billion JPY | 15.73% |
| 2023 | 190.39 Billion JPY | 7.97% |
| 2022 | 175.54 Billion JPY | 15.01% |
| 2021 | 151.37 Billion JPY | -6.62% |
| 2020 | 162.2 Billion JPY | 7.58% |
| 2019 | 147.43 Billion JPY | 0.77% |
| 2018 | 150.07 Billion JPY | 30.56% |
| 2017 | 122.58 Billion JPY | -2.72% |
| 2016 | 126.37 Billion JPY | 5.58% |
| 2015 | 108.14 Billion JPY | 7.69% |
| 2014 | 105.13 Billion JPY | 22.63% |
| 2013 | 85.52 Billion JPY | -3.62% |
| 2012 | 79.22 Billion JPY | 14.72% |
| 2011 | 72 Billion JPY | -7.58% |
| 2010 | 83.48 Billion JPY | 14.34% |
| 2009 | 72.96 Billion JPY | -15.54% |
| 2008 | 86.66 Billion JPY | 16.35% |
| 2007 | 75.52 Billion JPY | 22.78% |
| 2006 | 60.66 Billion JPY | 3.61% |
| 2005 | 63.11 Billion JPY | 19.83% |
| 2004 | 51.07 Billion JPY | 18.24% |
| 2003 | 41.32 Billion JPY | 4.16% |
| 2002 | 40.09 Billion JPY | -6.31% |
| 2001 | 42.34 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | 51.26 Billion JPY | -12.19% |
| 2024 Q1 | 48.2 Billion JPY | 12.33% |
| 2024 Q2 | 56.5 Billion JPY | 16.96% |
| 2024 Q3 | 59.47 Billion JPY | 4.86% |
| 2024 FY | - JPY | 40.58% |
| 2023 Q3 | 57.05 Billion JPY | 31.4% |
| 2023 Q1 | 47.54 Billion JPY | 27.19% |
| 2023 FY | - JPY | 7.97% |
| 2023 Q4 | 42.38 Billion JPY | -25.71% |
| 2023 Q2 | 43.41 Billion JPY | -8.68% |
| 2022 Q3 | 43.95 Billion JPY | -1.62% |
| 2022 Q4 | 37.38 Billion JPY | -14.96% |
| 2022 Q1 | 50.46 Billion JPY | 37.66% |
| 2022 Q2 | 44.68 Billion JPY | -11.45% |
| 2022 FY | - JPY | 15.01% |
| 2021 Q4 | 36.65 Billion JPY | 5.49% |
| 2021 FY | - JPY | -6.62% |
| 2021 Q1 | 18.47 Billion JPY | -51.86% |
| 2021 Q2 | 23.22 Billion JPY | 25.73% |
| 2021 Q3 | 34.74 Billion JPY | 49.6% |
| 2020 Q2 | 42.96 Billion JPY | 2.15% |
| 2020 FY | - JPY | 7.58% |
| 2020 Q4 | 38.37 Billion JPY | -5.9% |
| 2020 Q3 | 40.78 Billion JPY | -5.08% |
| 2020 Q1 | 42.06 Billion JPY | 5.22% |
| 2019 Q1 | 36.74 Billion JPY | -1.47% |
| 2019 FY | - JPY | 0.77% |
| 2019 Q4 | 39.97 Billion JPY | -6.11% |
| 2019 Q3 | 42.57 Billion JPY | 27.62% |
| 2019 Q2 | 33.36 Billion JPY | -9.21% |
| 2018 Q3 | 23.97 Billion JPY | -48.83% |
| 2018 Q1 | 33.09 Billion JPY | 97.33% |
| 2018 FY | - JPY | 30.56% |
| 2018 Q2 | 46.84 Billion JPY | 41.57% |
| 2018 Q4 | 37.29 Billion JPY | 55.59% |
| 2017 Q4 | 16.76 Billion JPY | -23.56% |
| 2017 Q3 | 21.93 Billion JPY | 33.17% |
| 2017 Q2 | 16.47 Billion JPY | 6.83% |
| 2017 FY | - JPY | -2.72% |
| 2017 Q1 | 15.42 Billion JPY | 23.31% |
| 2016 FY | - JPY | 5.58% |
| 2016 Q1 | 20.99 Billion JPY | 68.98% |
| 2016 Q2 | 15.49 Billion JPY | -26.2% |
| 2016 Q3 | 25.57 Billion JPY | 65.02% |
| 2016 Q4 | 12.5 Billion JPY | -51.09% |
| 2015 FY | - JPY | 7.69% |
| 2015 Q3 | 25.04 Billion JPY | 26.15% |
| 2015 Q4 | 12.42 Billion JPY | -50.38% |
| 2015 Q1 | 14.93 Billion JPY | 7.61% |
| 2015 Q2 | 19.85 Billion JPY | 32.92% |
| 2014 Q3 | 20.75 Billion JPY | 21.98% |
| 2014 Q4 | 13.87 Billion JPY | -33.13% |
| 2014 FY | - JPY | 22.63% |
| 2014 Q1 | 13.35 Billion JPY | 17.14% |
| 2014 Q2 | 17.01 Billion JPY | 27.45% |
| 2013 Q1 | 13.24 Billion JPY | 1.54% |
| 2013 Q4 | 11.39 Billion JPY | -31.92% |
| 2013 Q3 | 16.74 Billion JPY | 44.5% |
| 2013 Q2 | 11.58 Billion JPY | -12.53% |
| 2013 FY | - JPY | -3.62% |
| 2012 Q1 | 17.02 Billion JPY | -13.45% |
| 2012 FY | - JPY | 14.72% |
| 2012 Q2 | 14.61 Billion JPY | -14.18% |
| 2012 Q4 | 13.04 Billion JPY | -14.26% |
| 2012 Q3 | 15.21 Billion JPY | 4.1% |
| 2011 Q4 | 19.67 Billion JPY | -1.32% |
| 2011 FY | - JPY | -7.58% |
| 2011 Q3 | 19.93 Billion JPY | -3.26% |
| 2011 Q2 | 20.61 Billion JPY | 20.38% |
| 2011 Q1 | 17.12 Billion JPY | -8.29% |
| 2010 Q1 | 21.46 Billion JPY | 38.05% |
| 2010 FY | - JPY | 14.34% |
| 2010 Q3 | 23.23 Billion JPY | 14.34% |
| 2010 Q4 | 18.66 Billion JPY | -19.65% |
| 2010 Q2 | 20.32 Billion JPY | -5.31% |
| 2009 FY | - JPY | -15.54% |
| 2009 Q4 | 15.54 Billion JPY | 2.44% |
| 2009 Q3 | 15.17 Billion JPY | 8.3% |
| 2009 Q2 | 14.01 Billion JPY | 0.0% |
| 2008 FY | - JPY | 16.35% |
| 2007 FY | - JPY | 22.78% |
| 2006 FY | - JPY | 3.61% |
| 2005 FY | - JPY | 19.83% |
| 2004 FY | - JPY | 18.24% |
| 2003 FY | - JPY | 4.16% |
| 2002 FY | - JPY | -6.31% |
| 2001 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 22858970.859% |
| Ansell Limited | 209.86 Million USD | -104897.439% |
| Ansell Limited | 206.3 Million USD | -106709.985% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 42.83 Million USD | -514255.785% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 13560447.358% |
| Psykey, Inc. | -1.29 Million USD | 17011473.392% |
| ConvaTec Group Plc | 455.5 Million USD | -48275.192% |
| ConvaTec Group Plc | 455.5 Million USD | -48275.192% |
| Encision Inc. | -544.19 Thousand USD | 40490916.711% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 155383359.291% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 200444928.527% |
| Innovative MedTech Inc. | -7.67 Million USD | 2871539.337% |
| LifePoint, Inc. | -14.2 Million USD | 1551620.028% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 3561583.756% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 67799792.308% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | 102376583.269% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 54302142.466% |
| SmileDirectClub, Inc. | -186.13 Million USD | 118478.738% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | -49104.333% |
| SheerVision, Inc. | -110.53 Thousand USD | 199355032.1% |
| United Health Products, Inc. | -2.5 Million USD | 8806261.264% |
| Vasamed, Inc. | -4.57 Million USD | 4817059.096% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 9746881.579% |
| Yubo International Biotech Limited | -1.17 Million USD | 18710435.353% |